Trials / Unknown
UnknownNCT04686539
Synthetic CBD as a Therapy for COVID-19
Synthetic CBD Oil Droplets as a Therapy for Mild to Moderate SARS-CoV-2 Infection. Assesment of Efficacy and Safety.
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Sheba Medical Center · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aim to test proof of concept of CBD treatment for efficacy and safety in patients suffering with mild COVID-19 infection. The CBD will be delivered via oil droplets not containing THC, compared to placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CBD | CBD oil not containing THC, to be administered sub-lingual. |
| DRUG | Placebo | Placebo Oil |
Timeline
- Start date
- 2021-01-20
- Primary completion
- 2021-11-01
- Completion
- 2022-01-01
- First posted
- 2020-12-28
- Last updated
- 2021-09-28
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT04686539. Inclusion in this directory is not an endorsement.